Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLeft-sided pain is one of the more unsettling things people notice after starting Wegovy. In most cases it traces back to something straightforward, like trapped wind or digestive discomfort as your body adjusts to semaglutide. Occasionally, though, it can signal something that warrants medical attention. This page explains the likely causes, the warning signs that matter, and when to stop waiting and get help. Wegovy is a prescription-only medicine, and any new or unusual pain should always be mentioned to a clinician who knows your full history.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people who report left-sided pain on Wegovy describe it arriving in the first few days after a new pen or a dose increase. It often feels like a dull ache, cramping, or bloating somewhere between the lower ribs and the hip. That pattern fits neatly with how semaglutide works: it slows gastric emptying, which means food and gas spend longer in the digestive system. The result can be discomfort, pressure, or pain that shifts around the abdomen, not always neatly on one side.
A common misconception is that pain on the left specifically points to the spleen or the kidney. In most Wegovy users it does not. The descending colon runs down the left side of the abdomen, and gas trapped there is a very plausible culprit. The gas and bloating side effects of Wegovy are well recognised and tend to be most pronounced in the first few weeks of each dose level, then ease as the body settles.
Eating smaller portions, slowing down at mealtimes, and cutting back on high-fat or very fibrous foods temporarily can all help. The NHS semaglutide patient page lists practical lifestyle adjustments alongside a full run-down of the medicine's common side effects. Discomfort that is genuinely mild and fading over a few days is usually just your digestive system adjusting.
The pain picture changes when it becomes severe, comes on quickly, or does not pass. In January 2026 the MHRA issued a Drug Safety Update for GLP-1 receptor agonist medicines (including semaglutide) specifically flagging acute pancreatitis as an infrequent but serious risk. The key symptom is severe, persistent stomach pain that often radiates through to the back, sometimes accompanied by vomiting. If that describes what you are feeling, stop eating and drinking and go to A&E or call 999. Do not wait to see whether it settles overnight.
Gallbladder problems are another possibility. Rapid weight loss (the kind these medicines can produce) is a known risk factor for gallstones, and gallbladder inflammation can produce upper abdominal pain that is hard to localise precisely. It may feel central, right-sided, or occasionally left-of-centre, and it can be accompanied by nausea or a dull, aching pressure after eating fatty food. Your GP or an urgent care service can investigate with an ultrasound if gallbladder disease is suspected.
Pain under the lower-left ribs has its own pattern that is worth reading about separately. There is a dedicated page covering pain under the left rib on Wegovy for anyone whose discomfort is localised specifically there. And for pain that runs down into the leg, the leg pain and Wegovy page addresses that question specifically.
Any pain that is severe, sudden, spreading, or accompanied by a high temperature, yellowing of the skin, dark urine, or signs of dehydration is a medical emergency and needs same-day care.
Not all left-side pain starts from inside the abdomen. Wegovy is injected subcutaneously (usually into the abdomen, thigh, or upper arm) and if you have been rotating sites, the left abdomen is a common injection location. Redness, tenderness, or a small lump under the skin at the site are normal short-term reactions and usually resolve within a day or two. If the injection site becomes warm, swollen, or increasingly painful over time, it is worth having it looked at, as persistent localised reactions are less typical.
Skin-surface pain on Wegovy can also come from nerve sensitivity, especially if you are injecting close to the same spot repeatedly without rotating far enough. The guide to skin pain on Wegovy covers technique adjustments and when a reaction moves beyond expected. Rotating the site each week (and moving at least a few centimetres from the previous injection point) reduces the chance of localised irritation building up.
For a broader look at the side-effect profile of semaglutide as a medicine, the semaglutide side effects page sets out the full picture, including how common each effect is and which ones tend to fade with time.
If you are unsure whether your left-side pain is within the expected range, telling your prescriber is always the right move. They can take your full clinical history into account, ask about timing, character, and severity, and decide whether any investigation is needed before your next dose. Do not try to interpret pain by feel alone; that is exactly what clinical review is for.
The semaglutide overview on this site is a useful starting point for understanding what is typical at each stage of treatment, and the Wegovy treatment page covers eligibility and the prescription process in the UK. If you have questions about whether this medicine is right for you, our clinical team is available seven days a week, you can read more about who reviews prescriptions on our clinical team page.
Patients and healthcare professionals can report suspected side effects directly to the MHRA through the Yellow Card scheme. Reporting contributes to the ongoing safety monitoring that keeps GLP-1 medicine guidance current and accurate.
If any of what you have read here has raised questions about whether Wegovy is still the right treatment for you, or if you are weighing up your options, speaking to a prescriber is the sensible next step. At nume, all consultations are reviewed by a GPhC-registered Independent Prescriber, every time. You can speak to our prescribers through a free consultation, with no obligation and no waiting list.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.